Androstenedione is the preferred androgen source in hormone refractory prostate cancer Letter

Nima Sharifi; Richard J. Auchus

doi:10.1158/1078-0432.CCR-14-1123

Androstenedione is the preferred androgen source in hormone refractory prostate cancer Letter

Nima Sharifi, Richard J. Auchus

Internal Medicine

Research output: Contribution to journal › Letter › peer-review

9 Scopus citations

Original language	English (US)
Pages (from-to)	4971
Number of pages	1
Journal	Clinical Cancer Research
Volume	20
Issue number	18
DOIs	https://doi.org/10.1158/1078-0432.CCR-14-1123
State	Published - Sep 15 2014

ASJC Scopus subject areas

General Medicine

Access to Document

10.1158/1078-0432.CCR-14-1123

Cite this

@article{625ede0c5f4f481588d50d3ec55ad308,

title = "Androstenedione is the preferred androgen source in hormone refractory prostate cancer Letter",

author = "Nima Sharifi and Auchus, {Richard J.}",

year = "2014",

month = sep,

day = "15",

doi = "10.1158/1078-0432.CCR-14-1123",

language = "English (US)",

volume = "20",

pages = "4971",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "18",

}

TY - JOUR

T1 - Androstenedione is the preferred androgen source in hormone refractory prostate cancer Letter

AU - Sharifi, Nima

AU - Auchus, Richard J.

PY - 2014/9/15

Y1 - 2014/9/15

UR - http://www.scopus.com/inward/record.url?scp=84907438022&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907438022&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-14-1123

DO - 10.1158/1078-0432.CCR-14-1123

M3 - Letter

C2 - 25225065

AN - SCOPUS:84907438022

SN - 1078-0432

VL - 20

SP - 4971

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 18

ER -

Androstenedione is the preferred androgen source in hormone refractory prostate cancer Letter

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this